Development of selective immune tolerance towards the allogeneic fetus during pregnancy: Role of tryptophan catabolites (Review)

  • Authors:
    • Bao Ting Zhu
  • View Affiliations

  • Published online on: June 1, 2010     https://doi.org/10.3892/ijmm_00000411
  • Pages: 831-835
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Studies in recent years have shown that the selective expression of indoleamine 2,3-dioxygenase (IDO) in certain cell populations may play an important role in mediating immunosuppression. Mechanistically, since IDO is a rate-limiting enzyme of the kynurenine pathway responsible for tryptophan catabolism, the prevailing explanation for its immunosuppressive action is based on the assumption that the presence of IDO in selected cell populations would consume local tryptophan and subsequently starve adjacent maternal T-cells of this essential amino acid. In this review, an alternative hypothesis is discussed, which suggests that IDO is mainly expressed in various types of antigen-presenting cells (such as placental syncytiotrophoblasts during pregnancy), and that its main function is to produce biologically-active tryptophan catabolites that will mediate immunosuppression. Mechanistically, because these tryptophan catabolites are concentrated in a microenvironment surrounding the IDO-expressing dendritic cells, they will selectively suppress the proliferation of a sub-population of T-cells that are activated by the allogeneic antigen-presenting cells and ultimately wipe out this T-cell sub-population. Evidence in support of this new mechanistic explanation is discussed. This hypothesis provides an alternative mechanistic explanation for the development of selective immune tolerance towards the allogeneic fetus during pregnancy. Moreover, it also offers insights into the functional role of certain tryptophan catabolites produced by cancer cells in evading the body's immune surveillance, as well as the potential usefulness of tryptophan catabolites as pharmacological agents for the induction of selective long-term immune tolerance towards the allogeneic organ transplant.

Related Articles

Journal Cover

June 2010
Volume 25 Issue 6

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhu BT: Development of selective immune tolerance towards the allogeneic fetus during pregnancy: Role of tryptophan catabolites (Review) . Int J Mol Med 25: 831-835, 2010
APA
Zhu, B.T. (2010). Development of selective immune tolerance towards the allogeneic fetus during pregnancy: Role of tryptophan catabolites (Review) . International Journal of Molecular Medicine, 25, 831-835. https://doi.org/10.3892/ijmm_00000411
MLA
Zhu, B. T."Development of selective immune tolerance towards the allogeneic fetus during pregnancy: Role of tryptophan catabolites (Review) ". International Journal of Molecular Medicine 25.6 (2010): 831-835.
Chicago
Zhu, B. T."Development of selective immune tolerance towards the allogeneic fetus during pregnancy: Role of tryptophan catabolites (Review) ". International Journal of Molecular Medicine 25, no. 6 (2010): 831-835. https://doi.org/10.3892/ijmm_00000411